Recombinant human papillomavirus type 18 vaccine
US5820870A · kind A · utility
12Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 1995 |
| Grant date | Oct 13, 1998 |
| Priority date | — |
| Expiry date | Mar 22, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/918
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to vaccines for human papillomavirus type 18 and derivatives thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.